Pooled analysis reveals semaglutide shows good efficacy in older adults aged over 65 years

Credit: Unsplash/CC0 Public Domain

A new analysis of the STEP trials carried out by semaglutide manufacturer Novo Nordisk has analyzed various…

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *